NEU neuren pharmaceuticals limited

Take Over Opportunity

  1. 5,238 Posts.
    lightbulb Created with Sketch. 543
    The way I see this is simple:

    Current share price doesn't reflect the current development of science we own. Many valuations are saying $31.00+

    If you add another rare disease to the mix, this valuation will increase the new valuation.

    If you add in 3 more positive breakthroughs, the share valuation would be in excess of $100.00.

    So, if the current share price is $22.57, there is certainly only extreme upside. We are trading in profit, we expect these profits to grow exponentially and with new disease being treated, the current share price has a very long way to go, to get to a point of stabilisation.

    For me, it's one of the most simple stock picks around to generate further profits.

    xoxo

    Merry Christmas all.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$19.82
Change
-0.320(1.59%)
Mkt cap ! $2.503B
Open High Low Value Volume
$20.39 $20.83 $19.70 $21.46M 1.066M

Buyers (Bids)

No. Vol. Price($)
2 7078 $19.80
 

Sellers (Offers)

Price($) Vol. No.
$19.94 3500 1
View Market Depth
Last trade - 16.10pm 19/09/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.